Hearing Amylin Considering Sale -Reuters

by Charles Gross, Benzinga Editor

April 22, 2012 6:22 PM | 15 seconds read | Make a Comment

Amylin

AMLN

is considering a sale of the company, according to sources cited by

Reuters

. Amylin is attempting to fight off a law suit by investor Carl Icahn. The company recently rejected a $3.5 billion takeover offer from Bristol-Myers Squibb

BMY

Market News and Data brought to you by Benzinga APIs

Posted In: News Rumors Insider Trades M&A Pre-Market Outlook

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!